[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336889-105":59,"doc-detail-336889-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","mecom-locus-classical-transcript-isoforms-affect-tumor-immune-microenvironment-and-different-targets-in-ovarian-cancer-research-open-access","MECOM locus classical transcript isoforms affect tumor immune microenvironment and different targets in ovarian cancer - Research Open Access","","The MECOM locus is frequently amplified in high-grade serous ovarian carcinoma (HGSOC), yet links among MECOM transcript levels, patient prognosis, and modulation of the tumor immune microenvironment (TIME) remain insufficient, especially in large cohorts. Expression of MECOM transcripts was evaluated in 352 HGSOC patients and 88 normal ovarian tissues using combined GTEx/TCGA data. Two classical protein isoform transcripts were identified, and Cox and Kaplan-Meier analyses, together with a TIME evaluation algorithm, related isoform expression to survival and TIME status. ChIP-seq and RNA-seq after targeted silencing identified regulatory targets. Higher MECOM isoform expression associated with worse survival, potentially via cancer-associated fibroblasts and immunosuppressive populations, while EVI1 isoforms correlated with enhanced survival through CD8+ T cells and macrophage regulation and reduced JUN protein effects.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/mecom-locus-classical-transcript-isoforms-affect-tumor-immune-microenvironment-and-different-targets-in-ovarian-cancer-research-open-access/336889/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/mecom-locus-classical-transcript-isoforms-affect-tumor-immune-microenvironment-and-different-targets-in-ovarian-cancer-research-open-access/336889.png","ImageObject",300,407,{"name":92,"@type":93},"Sage","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-02","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What question does this study address about MECOM in HGSOC?","Question",{"text":112,"@type":113},"It examines how MECOM transcript isoforms relate to patient prognosis and how they may modulate the tumor immune microenvironment (TIME) in HGSOC patients, especially in large cohorts.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How many patient and tissue samples were analyzed?",{"text":117,"@type":113},"The study analyzed MECOM transcript expression in 352 HGSOC patients and 88 normal ovarian tissues using combined GTEx/TCGA data.",{"name":119,"@type":110,"acceptedAnswer":120},"What analytical methods were used to connect isoform expression with outcomes and TIME?",{"text":121,"@type":113},"The study used Cox proportional hazards regression, Kaplan–Meier survival curves, and a comprehensive TIME evaluation algorithm, and further used ChIP-seq and RNA sequencing after targeted silencing to identify regulatory targets.",{"name":123,"@type":110,"acceptedAnswer":124},"What overall association did the study find for MECOM and EVI1 isoform transcripts with survival?",{"text":125,"@type":113},"Higher MECOM isoform transcript expression correlated with poorer survival, while higher EVI1 isoform transcript levels were linked to enhanced survival, potentially through distinct immune and regulatory mechanisms.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},336889,1790148149,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},687197207057,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Lan etal. Journal of Ovarian Research (2024) 17:207 Journal of Ovarian Research  \n[https://doi.org/10.1186/s13048-024-01522-0](https://doi.org/10.1186/s13048-024-01522-0)  \nRESEARCH Open Access  \nMECOM Locus classical transcript isoforms affect tumor immune microenvironment and different targets in ovarian cancer  \nNing Lan 1,2, Shuheng Bai 1, Min Chen 1,2, Xuan Wang 1, Zhaode Feng3, Ying Gao 1, Beina Hui 1, Wen Ma 1,4, Xiangxiang Zhang 1, Fengyuan Hu 1, Wanyi Liu 1, Wenyang Li 1, Fang Wu 1 and Juan Ren 1*  \nAbstract  \nThe MECOM locus is a gene frequently amplified in high-grade serous ovarian carcinoma (HGSOC) . Nevertheless, the body of research examining the associations among MECOM transcripts, patient prognosis, and their role in modulating the tumor immune microenvironment (TIME) remains sparse, particularly in large cohorts. This study assessed the expression of MECOM transcripts in 352 HGSOC patients and 88 normal ovarian tissues from the combined GTEx/TCGA database. Using resources such as the UCSC Genome Browser, Ensembl, and NextProt, two transcripts corresponding to classical protein isoforms from MECOM were identified. Cox proportional hazards regression analysis, Kaplan-Meier survival curves, and a comprehensive TIME evaluation algorithm were employed to elucidate the connections between the expression levels of these transcripts and both patient prognosis and TIME status. Chromatin Immunoprecipitation sequencing (ChIP-seq) data for the two protein isoforms, as well as RNA sequencing data post-targeted silencing, were analyzed to identify potential regulatory targets of the different transcription factors. Elevated expression of the MECOM isoform transcripts was correlated with poorer survival in HGSOC patients, potentially through the modulation of cancer-associated fibroblasts (CAFs) and immunosuppressive cell populations. In contrast, higher levels of EVI1 isoform transcripts were linked to enhanced survival, possibly due to the regulation of CD8+ T cells, macrophages, and a reduction in the expression of JUN protein, or its DNA-binding activity on downstream genes. Diverse protein isoforms derived from MECOM were found to differential ly affect the survival and tumor development in ovarian cancer patients through specific mechanisms. Investigating the molecular mechanisms underlying disease pathogenesis and identifying potential drug target proteins at the level of splice variant isoforms were deemed crucial.  \nKeywords Isoforms, MECOM, High-grade serous ovarian carcinoma (HGSOC), Regulatory targets, Transcription factors, Tumor immune microenvironment (TIME)  \n*Correspondence: Juan Ren [869491533@qq.com](869491533@qq.com)  \n1Department of Radiotherapy, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi Province 710061, PR China 2Precision Medicine Center, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi Province 710061, PR China  \n3Center for Mitochondrial Biology and Medicine, The Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi’an Jiaotong University, Xi’an,  \nShaanxi Province 710061, PR China  \n4Department of Radiotherapy, Gansu Provincial Hospital, Lanzhou, Gansu Province730030, PR China  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to ","cbCaishv8XV8E9QN","https://ap.wps.com/l/cbCaishv8XV8E9QN","pdf",2723814,13,"English","# Introduction\n## MECOM locus in HGSOC and prognosis relevance\n## Genomic amplification and promoter organization","[{\"question\":\"What question does this study address about MECOM in HGSOC?\",\"answer\":\"It examines how MECOM transcript isoforms relate to patient prognosis and how they may modulate the tumor immune microenvironment (TIME) in HGSOC patients, especially in large cohorts.\"},{\"question\":\"How many patient and tissue samples were analyzed?\",\"answer\":\"The study analyzed MECOM transcript expression in 352 HGSOC patients and 88 normal ovarian tissues using combined GTEx/TCGA data.\"},{\"question\":\"What analytical methods were used to connect isoform expression with outcomes and TIME?\",\"answer\":\"The study used Cox proportional hazards regression, Kaplan–Meier survival curves, and a comprehensive TIME evaluation algorithm, and further used ChIP-seq and RNA sequencing after targeted silencing to identify regulatory targets.\"},{\"question\":\"What overall association did the study find for MECOM and EVI1 isoform transcripts with survival?\",\"answer\":\"Higher MECOM isoform transcript expression correlated with poorer survival, while higher EVI1 isoform transcript levels were linked to enhanced survival, potentially through distinct immune and regulatory mechanisms.\"}]","MECOM locus classical transcript isoforms affect tumor immune microenvironment and different targets in ovarian cancer - Research Open Access | PDF",1790016974,33,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/85ad6fe72794fd4ddf1192bca9bd4cf4.webp",983,1310,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0d23a296e3888615d52d87e96515b65e.webp",982,1309,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0f7bd1e7faff7d393a029c2bc31ab724.webp",981,1308,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9e665a0e5d6fc566f2e53061ff44aed0.webp",980,1306]